Organizational capacity to address co-occurring substance use and psychiatric disorders: Assessing variation by level of care

Journal of Addiction Medicine

Volumn 7, Issue 1, 2013, Pages 25-32

  Lambert Harris, Chantal ^a   Saunders, Elizabeth C ^b   McGovern, Mark P ^a   Xie, Haiyi ^b  

^a DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Behavioral health; Co occurring disorder; Dual diagnosis; Integrated treatment; Level of care

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; COMMUNITY CARE; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DUAL DIAGNOSIS CAPABILITY OF ADDICTION TREATMENT INDEX; FEMALE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; RESIDENTIAL CARE; STANDARDIZATION;

ADULT; BEHAVIOR, ADDICTIVE; BENCHMARKING; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PATIENT CARE MANAGEMENT; QUALITY ASSURANCE, HEALTH CARE; RESIDENTIAL TREATMENT; SUBSTANCE ABUSE TREATMENT CENTERS; UNITED STATES;

EID: 84877991055     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318276e7a4     Document Type: Article

References (37)

1. Center for Substance Abuse Treatment (CSAT). Substance Abuse Treatment for Persons With Co-occurring Disorders. Treatment Improvement Protocol (TIP) Series, No. 42. DHHS publication No. (SMA) 05-3992. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2005.
2. Coffey SF, Schumacher JA, Brimo ML, Brady KT. Exposure therapy for substance abusers with PTSD: translating research to practice. Behav Modif 2005;29(1): 10-38. Available at: http://bmo. sagepub. com/cgi/content/abstract/ 29/1/10. Accessed July 12, 2006.
3. Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiat Serv 2001;52(4): 469-476. Available at: http://ps. psychiatryonline. org/cgi/content/abstract/52/ 4/469. Accessed December 6, 2007.
4. Ducharme L, Knudsen H, Roman P. Availability of integrated care for cooccurring substance abuse and psychiatric conditions. Community Ment Hlt J 2006;42(4): 363-375. Available at: http://dx. doi. org/10. 1007/s10597- 005-9030-7. Accessed November 21, 2007.
5. Ducharme L, Mello H, Roman P, Knudsen H, Johnson J. Service delivery in substance abuse treatment: reexamining comprehensive care. J Behav Health Ser R 2007;34(2): 121-136. Available at: http://dx. doi. org/10. 1007/s11414-007-9061- 7. Accessed June 26, 2012.
6. Giard J, Kincaid R, Gotham HJ, et al. The dual diagnosis capability in addiction treatment (DDCAT) toolkit. 2011. Available at: http://www. samhsa. gov/cooccurring/ddcat/. Accessed December 21, 2011.
7. Gil-Rivas V, Grella CE. Addictions services treatment services and service delivery models for dually diagnosed clients: variations across mental health and substance abuse providers. Community Ment Hlt J 2005;41(3): 251- 266. Available at: http://dx. doi. org/10. 1007/s10597-005-5000-3. Accessed January 24, 2008.
8. Gotham HJ, Brown JL, Comaty JE, McGovern MP, Claus RE. The dual diagnosis capability in mental health treatment (DDCMHT) index. Paper presented at: The annual Addiction Health Services Research conference; October, 2009; San Francisco, CA.
9. Gotham HJ, Claus RE, Selig K, Homer AL. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics. J Subst Abuse Treat 2010;38(2): 160-169.
10. Hart GL, Larson EH, Lishner DM. Rural definitions for health policy and research. Am J Public Health 2005;95(7): 1149-1155.
11. Knudsen HK, Roman PM, Ducharme LJ. The availability of psychiatric programs in private substance abuse treatment centers, 1995 to 2001. Psychiat Serv 2004;55(3): 270-273. Available at: http://ps. psychiatryonline. org/cgi/content/abstract/55/3/270. Accessed November 21, 2007.
12. Lee N, Cameron J. Differences in self and independent ratings on an organisational dual diagnosis capacity measure. Drug Alcohol Rev 2009;28(6): 682-684.
13. Mangrum LF, Spence RT, Lopez M. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. J Subst Abuse Treat 2006;30(1): 79-84. Available at: http://www. sciencedirect. com/science/article/ B6T90-4HWXCDJ-B/2/0941bedb 44302062208dac24cd23ac70. Accessed January 3, 2008.
14. McGovern MP, Giard J. Services research with co-occurring disorders: applications of the DDCAT index. Paper presented at: The annual Addiction Heath Service Research conference; October, 2007; Athens, GA.
15. McGovern MP, Lambert-Harris C, McHugo GJ, Giard J, Mangrum L. Improving the dual diagnosis capability of addiction and mental health treatment services: implementation factors associated with program level changes. J Dual Diagnosis 2010;6: 237-250.
16. McGovern MP, Carroll KM. Evidence-based practices for substance use disorders. Psychiat Clin N Am 2003;26(4): 991-1010.
17. McGovern MP, Matzkin AL, Giard J. Assessing the dual diagnosis capability of addiction treatment services: the dual diagnosis capability in addiction treatment (DDCAT) index. J Dual Diagn 2007;3: 111-123.
18. McGovern MP, Mc Lellan AT. The status of addiction treatment research with co-occurring substance use and psychiatric disorders. J Subst Abuse Treat 2008;34(1): 1-2. Available at: http://www. sciencedirect. com/science/article/ B6T90-4P00S19-4/2/9b819ed7e83282 8b9db1332a9c35b0b7. Accessed January 16, 2009.
19. McGovern MP, Xie H, Acquilano S, Segal SR, Siembab L, Drake RE. Addiction treatment services and co-occurring disorders: the ASAMPPC- 2R taxonomy of program dual diagnosis capability. J Addict Dis 2007;26(3): 27-37.
20. McGovern MP, Xie H, Segal SR, Siembab L, Drake RE. Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers. J Subst Abuse Treat 2006;31(3): 267-275. Available at: http://www. sciencedirect. com/science/article/B6T90-4KGG5VY- 2/2/ 8e72fd34a220a9416e820f8d25c227ad. Accessed June 26, 2012.
21. McLellan AT, Chalk M, Bartlett J. Outcomes, performance, and quality - what's the difference? J Subst Abuse Treat 2007;32(4): 331-340 Available at: http://www. sciencedirect. com/science/article/B6T90-4MHPHK9- 3/2/f60b23f3b5881fefb4df00e2a52a2579. Accessed January 15, 2008.
22. McLellan AT, Woody GE, Metzger D. Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons. Milbank Q 1996;74(1): 51-85.
23. Mee-Lee D, Schulman GD, Fishman M, Gastfriend DR, Griffith JH. ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders. Chevy Chase, MD: American Society of Addiction Medicine; 2001.
24. Mojtabai R. Which substance abuse treatment facilities offer dual diagnosis programs? Am J Drug Alcohol Ab 2004;30(3): 525-536.
25. Moos R, Schaefer J, Andrassy J, Moos B. Outpatient mental health care, self-help groups, and patients' one-year treatment outcomes. J Clin Psychol 2001;57(3): 273-287. Available at: http://search. ebscohost. com/login. aspx?direct=true&db=aph&AN=4481288& site=ehost-live. Accessed January 15, 2008.
26. New Freedom Commission on Mental Health. Achieving the Promise: Transforming Mental Health Care in America. DHHS Publication No. (SMA) 03-3832. Rockville, MD: New Freedom Commission on Mental Health, 2003.
27. O'Brien CP, Charney DS, Lewis L, et al. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiat 2004;56(10): 703-713. Available at: http://www. sciencedirect. com/science/article/B6T4S-4DTS85T- 5/2/ 1b1d3e906555c107cc7c5bfdb8ca36d2. Accessed January 2, 2008.
28. Ouimette P, Moos RH, Finney JW. PTSD treatment and 5-year remission among patients with substance use and post-traumatic stress disorders. J Consult Clin Psychol 2003;71(2): 410-414.
29. Sacks S, Chandler R, Gonzales J. Responding to the challenge of cooccurring disorders: suggestions for future research. J Subst Abuse Treat 2008;34(1): 139-146.
30. SPSS 17. 0 for Windows [computer program]. Chicago, IL: SPSS, Inc, 2008.
31. Stilen P, Baehni SA. Collaborative Response: Addressing the Needs of Consumers With Co-occurring Substance Use and Mental Health Disorders. 4th ed. Kansas City, MO: Mid-America Addiction Technology Transfer Center, 2002.
32. Substance Abuse and Mental Health Services Administration (SAMHSA). Office of Applied Studies. National Survey of Substance Abuse Treatment Services (N-SSATS): 2000. Data on substance abuse treatment facilities, DASIS Series: S-16, DHHS Publication No. (SMA) 02-3668, Rockville, MD: SAMHSA, 2002. Available at: http://www. samhsa. gov/data/DASIS/00nnstas/nssats2000report. pdf. Accessed August 13, 2012.
33. Substance Abuse and Mental Health Services Administration (SAMHSA). Report to Congress on the Prevention and Treatment of Cooccurring Substance Abuse Disorders and Mental Disorders. Rockville, MD: SAMHSA, US Department of Health and Human Services, 2002.
34. Substance Abuse and Mental Health Services Administration (SAMHSA). Strategies for Developing Treatment Programs for People With Cooccurring Substance Abuse and Mental Disorders. HHS Publication No. 3782. Rockville, MD: SAMHSA, US Department of Health and Human Services, 2003.
35. Substance Abuse and Mental Health Services Administration. Results From the 2009 National Survey on Drug Use and Health: Mental Health Findings. NSDUH Series H-39, HHS Publication No. (SMA) 10-4609. Rockville, MD: Center for Behavioral Health Statistics and Quality, 2010.
36. Timko C, Dixon K, Moos R. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems. Ment Health Serv Res 2005;7(4): 229-242. Available at: http://dx. doi. org/10. 1007/s11020-005- 7455-9. Accessed January 3, 2008.
37. Watkins KE, Hunter SB, Wenzel SL, et al. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. Am J Drug Alcohol Ab 2004;30(4): 749-764.